Atlas Trials

Phase I/II Study of SRP-4053 in DMD Patients

Clinical trial NCT02310906 · COMPLETED

Trial details

NCT number
NCT02310906
Sponsor
Sarepta Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Duchenne Muscular Dystrophy
Start date
2015-01-13
Primary completion
2019-03-25
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.